Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 293 (5537): 2108-2111

Copyright © 2001 by the American Association for the Advancement of Science

BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF

Jeffrey S. Thompson,1 Sarah A. Bixler,1 Fang Qian,1 Kalpit Vora,1* Martin L. Scott,1 Teresa G. Cachero,1 Catherine Hession,1 Pascal Schneider,2 Irene D. Sizing,1 Colleen Mullen,1 Kathy Strauch,1 Mohammad Zafari,1 Christopher D. Benjamin,1 Jurg Tschopp,2 Jeffrey L. Browning,1 Christine Ambrose1dagger

B cell homeostasis has been shown to critically depend on BAFF, the B cell activation factor from the tumor necrosis factor (TNF) family. Although BAFF is already known to bind two receptors, BCMA and TACI, we have identified a third receptor for BAFF that we have termed BAFF-R. BAFF-R binding appears to be highly specific for BAFF, suggesting a unique role for this ligand-receptor interaction. Consistent with this, the BAFF-R locus is disrupted in A/WySnJ mice, which display a B cell phenotype qualitatively similar to that of the BAFF-deficient mice. Thus, BAFF-R appears to be the principal receptor for BAFF-mediated mature B cell survival.

1 Biogen, 12 Cambridge Center, Cambridge, MA 02142, USA.
2 The Institute of Biochemistry, University of Lausanne, CH-1066, Epalinges, Switzerland.
*   Present address: Department of Biologics Research, Merck & Co., 126 East Lincoln Avenue, RY 80Y-310, Rahway, NJ 07065, USA.

dagger    To whom correspondence should be addressed. E-mail: christine_ambrose{at}biogen.com



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
BAFF Receptor Deficiency Limits Gammaherpesvirus Infection.
B. Frederico, J. S. May, S. Efstathiou, and P. G. Stevenson (2014)
J. Virol. 88, 3965-3975
   Abstract »    Full Text »    PDF »
Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation.
R. Goenka, A. H. Matthews, B. Zhang, P. J. O'Neill, J. L. Scholz, T.-S. Migone, W. J. Leonard, W. Stohl, U. Hershberg, and M. P. Cancro (2014)
J. Exp. Med. 211, 45-56
   Abstract »    Full Text »    PDF »
BAFF and TACI Gene Expression Are Increased in Patients with Untreated Very Early Rheumatoid Arthritis.
R. A. Moura, H. Canhao, J. Polido-Pereira, A. M. Rodrigues, M. Navalho, A. F. Mourao, C. Resende, R. Campanilho-Marques, J. Madruga Dias, J. A. P. da Silva, et al. (2013)
J Rheumatol 40, 1293-1302
   Abstract »    Full Text »    PDF »
B-Cell Activating Factor Promoter Polymorphisms in Egyptian Patients with Systemic Lupus Erythematosus.
R. A. Zayed, H. F. Sheba, M. A. K. Abo Elazaem, Z. A. Elsaadany, L. O. Elmessery, J. A. Mahmoud, D. R. Abdel Rahman, and F. R. Abdou (2013)
Ann. Clin. Lab. Sci. 43, 289-294
   Abstract »    Full Text »    PDF »
Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study.
W. Stohl, J. T. Merrill, J. D. McKay, J. R. Lisse, Z. J. Zhong, W. W. Freimuth, and M. C. Genovese (2013)
J Rheumatol 40, 579-589
   Abstract »    Full Text »    PDF »
Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells.
J. Zhou, K. Tiemann, P. Chomchan, J. Alluin, P. Swiderski, J. Burnett, X. Zhang, S. Forman, R. Chen, and J. Rossi (2013)
Nucleic Acids Res. 41, 4266-4283
   Abstract »    Full Text »    PDF »
Critical Role of B Cell Lymphoma 10 in BAFF-Regulated NF-{kappa}B Activation and Survival of Anergic B Cells.
M. Yu, Y. Chen, Y. He, A. Podd, G. Fu, J. A. Wright, E. Kleiman, W. N. Khan, R. Wen, and D. Wang (2012)
J. Immunol. 189, 5185-5193
   Abstract »    Full Text »    PDF »
APRIL Binding to BCMA Activates a JNK2-FOXO3-GADD45 Pathway and Induces a G2/M Cell Growth Arrest in Liver Cells.
G. Notas, V.-I. Alexaki, M. Kampa, V. Pelekanou, I. Charalampopoulos, S. Sabour-Alaoui, I. Pediaditakis, V. Dessirier, A. Gravanis, E. N. Stathopoulos, et al. (2012)
J. Immunol. 189, 4748-4758
   Abstract »    Full Text »    PDF »
Essential Role for CAML in Follicular B Cell Survival and Homeostasis.
N. A. Zane, J. H. Gundelach, L. D. Lindquist, and R. J. Bram (2012)
J. Immunol. 188, 3009-3018
   Abstract »    Full Text »    PDF »
The Yin and Yang of Immunomodulatory Biologics: Assessing the Delicate Balance between Benefit and Risk.
D. M. Danilenko and H. Wang (2012)
Toxicol Pathol 40, 272-287
   Abstract »    Full Text »    PDF »
Formation of B-1 B Cells from Neonatal B-1 Transitional Cells Exhibits NF-{kappa}B Redundancy.
E. Montecino-Rodriguez and K. Dorshkind (2011)
J. Immunol. 187, 5712-5719
   Abstract »    Full Text »    PDF »
Induction of the Alternative NF-{kappa}B Pathway by Lymphotoxin {alpha}{beta} (LT{alpha}{beta}) Relies on Internalization of LT{beta} Receptor.
C. Ganeff, C. Remouchamps, L. Boutaffala, C. Benezech, G. Galopin, S. Vandepaer, F. Bouillenne, S. Ormenese, A. Chariot, P. Schneider, et al. (2011)
Mol. Cell. Biol. 31, 4319-4334
   Abstract »    Full Text »    PDF »
Noncanonical NF-{kappa}B regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development.
H. Hu, X. Wu, W. Jin, M. Chang, X. Cheng, and S.-C. Sun (2011)
PNAS 108, 12827-12832
   Abstract »    Full Text »    PDF »
Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.
M. Guadagnoli, F. C. Kimberley, U. Phan, K. Cameron, P. M. Vink, H. Rodermond, E. Eldering, A. P. Kater, H. van Eenennaam, and J. P. Medema (2011)
Blood 117, 6856-6865
   Abstract »    Full Text »    PDF »
B Cell Maturation Antigen Deficiency Exacerbates Lymphoproliferation and Autoimmunity in Murine Lupus.
C. Jiang, W. M. Loo, E. J. Greenley, K. S. Tung, and L. D. Erickson (2011)
J. Immunol. 186, 6136-6147
   Abstract »    Full Text »    PDF »
Somatically Diversified and Proliferating Transitional B Cells: Implications for Peripheral B Cell Homeostasis.
V. A. Yeramilli and K. L. Knight (2011)
J. Immunol. 186, 6437-6444
   Abstract »    Full Text »    PDF »
Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses.
Y. Chang, Y. Wu, D. Wang, W. Wei, Q. Qin, G. Xie, L. Zhang, S. Yan, J. Chen, Q. Wang, et al. (2011)
Rheumatology 50, 862-870
   Abstract »    Full Text »    PDF »
Macrophage-derived BAFF induces AID expression through the p38MAPK/CREB and JNK/AP-1 pathways.
H.-A. Kim, G.-Y. Seo, and P.-H. Kim (2011)
J. Leukoc. Biol. 89, 393-398
   Abstract »    Full Text »    PDF »
Suppressive Effect of Bacterial Polysaccharides on BAFF System Is Responsible for Their Poor Immunogenicity.
S. Kanswal, N. Katsenelson, W. Allman, K. Uslu, M. S. Blake, and M. Akkoyunlu (2011)
J. Immunol. 186, 2430-2443
   Abstract »    Full Text »    PDF »
Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-{kappa}B-inducing kinase while activating both canonical and alternative nuclear factor-{kappa}B pathways.
L. V. Pham, L. Fu, A. T. Tamayo, C. Bueso-Ramos, E. Drakos, F. Vega, L. J. Medeiros, and R. J. Ford (2011)
Blood 117, 200-210
   Abstract »    Full Text »    PDF »
Persistent Friend Virus Replication and Disease in Apobec3-Deficient Mice Expressing Functional B-Cell-Activating Factor Receptor.
M. L. Santiago, D. S. Smith, B. S. Barrett, M. Montano, R. L. Benitez, R. Pelanda, K. J. Hasenkrug, and W. C. Greene (2011)
J. Virol. 85, 189-199
   Abstract »    Full Text »    PDF »
A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling.
J. M. Hildebrand, Z. Luo, M. K. Manske, T. Price-Troska, S. C. Ziesmer, W. Lin, B. S. Hostager, S. L. Slager, T. E. Witzig, S. M. Ansell, et al. (2010)
J. Exp. Med. 207, 2569-2579
   Abstract »    Full Text »    PDF »
Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
L. Zhao, Y. Li, M. Smith Jr, J. Wang, W. Zhang, F. Tang, X. Tian, H. Wang, F. Zhang, D. Ba, et al. (2010)
Lupus 19, 1534-1549
   Abstract »    PDF »
Atacicept: targeting B cells in multiple sclerosis.
H.-P. Hartung and B. C. Kieseier (2010)
Therapeutic Advances in Neurological Disorders 3, 205-216
   Abstract »    PDF »
Persistence of Viremia and Production of Neutralizing Antibodies Differentially Regulated by Polymorphic APOBEC3 and BAFF-R Loci in Friend Virus-Infected Mice.
S. Tsuji-Kawahara, T. Chikaishi, E. Takeda, M. Kato, S. Kinoshita, E. Kajiwara, S. Takamura, and M. Miyazawa (2010)
J. Virol. 84, 6082-6095
   Abstract »    Full Text »    PDF »
A Functional Receptor for B-Cell-Activating Factor Is Expressed on Human Acute Lymphoblastic Leukemias.
R. Parameswaran, M. Muschen, Y.-m. Kim, J. Groffen, and N. Heisterkamp (2010)
Cancer Res. 70, 4346-4356
   Abstract »    Full Text »    PDF »
Requirement for BAFF and APRIL during B Cell Development in GALT.
V. A. Yeramilli and K. L. Knight (2010)
J. Immunol. 184, 5527-5536
   Abstract »    Full Text »    PDF »
Putative GTPase GIMAP1 is critical for the development of mature B and T lymphocytes.
A. Saunders, L. M. C. Webb, M. L. Janas, A. Hutchings, J. Pascall, C. Carter, N. Pugh, G. Morgan, M. Turner, and G. W. Butcher (2010)
Blood 115, 3249-3257
   Abstract »    Full Text »    PDF »
Peripheral B Cell Tolerance and Function in Transgenic Mice Expressing an IgD Superantigen.
B. H. Duong, T. Ota, D. Ait-Azzouzene, M. Aoki-Ota, J. L. Vela, C. Huber, K. Walsh, A. L. Gavin, and D. Nemazee (2010)
J. Immunol. 184, 4143-4158
   Abstract »    Full Text »    PDF »
A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival.
R. B. Henderson, K. Grys, A. Vehlow, C. de Bettignies, A. Zachacz, T. Henley, M. Turner, F. Batista, and V. L. J. Tybulewicz (2010)
J. Exp. Med. 207, 837-853
   Abstract »    Full Text »    PDF »
Autoantibody-producing RP105- B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects.
S. Koarada, Y. Tada, Y. Sohma, Y. Haruta, R. Suematsu, M. Mitamura, H. Inoue, H. Ehara, Y. Tokoro, A. Ohta, et al. (2010)
Rheumatology 49, 662-670
   Abstract »    Full Text »    PDF »
The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia.
X.-j. Zhu, Y. Shi, J. Peng, C.-s. Guo, N.-n. Shan, P. Qin, X.-b. Ji, and M. Hou (2009)
Blood 114, 5362-5367
   Abstract »    Full Text »    PDF »
Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.
M. W. Tusche, L. A. Ward, F. Vu, D. McCarthy, M. Quintela-Fandino, J. Ruland, J. L. Gommerman, and T. W. Mak (2009)
J. Exp. Med. 206, 2671-2683
   Abstract »    Full Text »    PDF »
Absence of Mature Peripheral B Cell Populations in Mice with Concomitant Defects in B Cell Receptor and BAFF-R Signaling.
K. L. Hoek, G. Carlesso, E. S. Clark, and W. N. Khan (2009)
J. Immunol. 183, 5630-5643
   Abstract »    Full Text »    PDF »
Adipocytes as Immune Cells: Differential Expression of TWEAK, BAFF, and APRIL and Their Receptors (Fn14, BAFF-R, TACI, and BCMA) at Different Stages of Normal and Pathological Adipose Tissue Development.
V.-I. Alexaki, G. Notas, V. Pelekanou, M. Kampa, M. Valkanou, P. Theodoropoulos, E. N. Stathopoulos, A. Tsapis, and E. Castanas (2009)
J. Immunol. 183, 5948-5956
   Abstract »    Full Text »    PDF »
B Cell Receptor and BAFF Receptor Signaling Regulation of B Cell Homeostasis.
W. N. Khan (2009)
J. Immunol. 183, 3561-3567
   Abstract »    Full Text »    PDF »
B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans.
K. Warnatz, U. Salzer, M. Rizzi, B. Fischer, S. Gutenberger, J. Bohm, A.-K. Kienzler, Q. Pan-Hammarstrom, L. Hammarstrom, M. Rakhmanov, et al. (2009)
PNAS 106, 13945-13950
   Abstract »    Full Text »    PDF »
Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia.
K. S. Kim, J.-Y. Park, I. Jou, and S. M. Park (2009)
J. Leukoc. Biol. 86, 349-359
   Abstract »    Full Text »    PDF »
CD4+CD25+ T-Cells Control Autoimmunity in the Absence of B-Cells.
E. Marino, J. Villanueva, S. Walters, D. Liuwantara, F. Mackay, and S. T. Grey (2009)
Diabetes 58, 1568-1577
   Abstract »    Full Text »    PDF »
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation.
M. Gupta, S. R. Dillon, S. C. Ziesmer, A. L. Feldman, T. E. Witzig, S. M. Ansell, J. R. Cerhan, and A. J. Novak (2009)
Blood 113, 5206-5216
   Abstract »    Full Text »    PDF »
Genetic Variation in B-Cell-Activating Factor Is Associated with an Increased Risk of Developing B-Cell Non-Hodgkin Lymphoma.
A. J. Novak, S. L. Slager, Z. S. Fredericksen, A. H. Wang, M. M. Manske, S. Ziesmer, M. Liebow, W. R. Macon, S. R. Dillon, T. E. Witzig, et al. (2009)
Cancer Res. 69, 4217-4224
   Abstract »    Full Text »    PDF »
An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus.
C. Pena-Rossi, E. Nasonov, M. Stanislav, V. Yakusevich, O. Ershova, N. Lomareva, H. Saunders, J. Hill, and I. Nestorov (2009)
Lupus 18, 547-555
   Abstract »    PDF »
The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
F. C. Kimberley, L. van Bostelen, K. Cameron, G. Hardenberg, J. A. Marquart, M. Hahne, and J. P. Medema (2009)
FASEB J 23, 1584-1595
   Abstract »    Full Text »    PDF »
The Lack of Epithelial Interleukin-7 and BAFF/BLyS Gene Expression in Prostate Cancer as a Possible Mechanism of Tumor Escape from Immunosurveillance.
E. Di Carlo, T. D'Antuono, P. Pompa, R. Giuliani, S. Rosini, L. Stuppia, P. Musiani, and C. Sorrentino (2009)
Clin. Cancer Res. 15, 2979-2987
   Abstract »    Full Text »    PDF »
The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death.
S.-J. Lee, M. Long, A. J. Adler, R. S. Mittler, and A. T. Vella (2009)
J. Leukoc. Biol. 85, 175-185
   Abstract »    Full Text »    PDF »
BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells.
K. L. Otipoby, Y. Sasaki, M. Schmidt-Supprian, A. Patke, R. Gareus, M. Pasparakis, A. Tarakhovsky, and K. Rajewsky (2008)
PNAS 105, 12435-12438
   Abstract »    Full Text »    PDF »
Deficient TACI Expression on B Lymphocytes of Newborn Mice Leads to Defective Ig Secretion in Response to BAFF or APRIL.
S. Kanswal, N. Katsenelson, A. Selvapandiyan, R. J. Bram, and M. Akkoyunlu (2008)
J. Immunol. 181, 976-990
   Abstract »    Full Text »    PDF »
Global T Cell Dysregulation in Non-Autoimmune-Prone Mice Promotes Rapid Development of BAFF-Independent, Systemic Lupus Erythematosus-Like Autoimmunity.
W. Stohl, N. Jacob, W. J. Quinn III, M. P. Cancro, H. Gao, C. Putterman, X. Gao, L. Pricop, and M. N. Koss (2008)
J. Immunol. 181, 833-841
   Abstract »    Full Text »    PDF »
A unique B2 B cell subset in the intestine.
Y. Shimomura, A. Ogawa, M. Kawada, K. Sugimoto, E. Mizoguchi, H.-N. Shi, S. Pillai, A. K. Bhan, and A. Mizoguchi (2008)
J. Exp. Med. 205, 1343-1355
   Abstract »    Full Text »    PDF »
B Lymphocyte Stimulator Regulates Adaptive Immune Responses by Directly Promoting Dendritic Cell Maturation.
S. K. Chang, S. A. Mihalcik, and D. F. Jelinek (2008)
J. Immunol. 180, 7394-7403
   Abstract »    Full Text »    PDF »
Treating patients with lupus with B-cell depletion.
D. Isenberg (2008)
Lupus 17, 400-404
   Abstract »    PDF »
BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells.
G. Badr, G. Borhis, E. A. Lefevre, N. Chaoul, F. Deshayes, V. Dessirier, G. Lapree, A. Tsapis, and Y. Richard (2008)
Blood 111, 2744-2754
   Abstract »    Full Text »    PDF »
Phase I Clinical Study of Atacicept in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma.
S. M. Ansell, T. E. Witzig, D. J. Inwards, L. F. Porrata, A. Ythier, L. Ferrande, I. Nestorov, T. DeVries, S. R. Dillon, D. Hausman, et al. (2008)
Clin. Cancer Res. 14, 1105-1110
   Abstract »    Full Text »    PDF »
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.
R. T. Woodland, C. J. Fox, M. R. Schmidt, P. S. Hammerman, J. T. Opferman, S. J. Korsmeyer, D. M. Hilbert, and C. B. Thompson (2008)
Blood 111, 750-760
   Abstract »    Full Text »    PDF »
Regulated Expression of BAFF-Binding Receptors during Human B Cell Differentiation.
J. R. Darce, B. K. Arendt, X. Wu, and D. F. Jelinek (2007)
J. Immunol. 179, 7276-7286
   Abstract »    Full Text »    PDF »
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade.
W. Y. Lin, Q. Gong, D. Seshasayee, Z. Lin, Q. Ou, S. Ye, E. Suto, J. Shu, W. Pun Lee, C.-W. V. Lee, et al. (2007)
Blood 110, 3959-3967
   Abstract »    Full Text »    PDF »
In Vitro and In Vivo Activation Induces BAFF and APRIL Expression in B Cells.
V. T. Chu, P. Enghard, G. Riemekasten, and C. Berek (2007)
J. Immunol. 179, 5947-5957
   Abstract »    Full Text »    PDF »
Antibody targeting of B-cell maturation antigen on malignant plasma cells.
M. C. Ryan, M. Hering, D. Peckham, C. F. McDonagh, L. Brown, K. M. Kim, D. L. Meyer, R. F. Zabinski, I. S. Grewal, and P. J. Carter (2007)
Mol. Cancer Ther. 6, 3009-3018
   Abstract »    Full Text »    PDF »
Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates.
K. Kaur, S. Chowdhury, N. S. Greenspan, and J. R. Schreiber (2007)
Blood 110, 2948-2954
   Abstract »    Full Text »    PDF »
Neutralizing B-Cell Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model.
P. Neri, S. Kumar, M. T. Fulciniti, S. Vallet, S. Chhetri, S. Mukherjee, Y. Tai, D. Chauhan, P. Tassone, S. Venuta, et al. (2007)
Clin. Cancer Res. 13, 5903-5909
   Abstract »    Full Text »    PDF »
Bruton's Tyrosine Kinase Mediates NF-{kappa}B Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family.
N. P. Shinners, G. Carlesso, I. Castro, K. L. Hoek, R. A. Corn, R. L. Woodland, M. L. Scott, D. Wang, and W. N. Khan (2007)
J. Immunol. 179, 3872-3880
   Abstract »    Full Text »    PDF »
Identification of a Novel Immunosubversion Mechanism Mediated by a Virologue of the B-Lymphocyte Receptor TACI.
J. R. Grant, A. R. Moise, and W. A. Jefferies (2007)
Clin. Vaccine Immunol. 14, 907-917
   Abstract »    Full Text »    PDF »
TLR Stimulation Modifies BLyS Receptor Expression in Follicular and Marginal Zone B Cells.
L. S. Treml, G. Carlesso, K. L. Hoek, J. E. Stadanlick, T. Kambayashi, R. J. Bram, M. P. Cancro, and W. N. Khan (2007)
J. Immunol. 178, 7531-7539
   Abstract »    Full Text »    PDF »
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjogren's syndrome and systemic lupus erythematosus.
J. Sellam, C. Miceli-Richard, J.-E. Gottenberg, M. Ittah, F. Lavie, C. Lacabaratz, N. Gestermann, A. Proust, O. Lambotte, and X. Mariette (2007)
Ann Rheum Dis 66, 790-797
   Abstract »    Full Text »    PDF »
A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
S. Peron, Q. Pan-Hammarstrom, K. Imai, L. Du, N. Taubenheim, O. Sanal, L. Marodi, A. Bergelin-Besancon, M. Benkerrou, J.-P. de Villartay, et al. (2007)
J. Exp. Med. 204, 1207-1216
   Abstract »    Full Text »    PDF »
Divergent Effects of BAFF on Human Memory B Cell Differentiation into Ig-Secreting Cells.
J. R. Darce, B. K. Arendt, S. K. Chang, and D. F. Jelinek (2007)
J. Immunol. 178, 5612-5622
   Abstract »    Full Text »    PDF »
Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese.
A. Kawasaki, N. Tsuchiya, J. Ohashi, Y. Murakami, T. Fukazawa, M. Kusaoi, S. Morimoto, K. Matsuta, H. Hashimoto, Y. Takasaki, et al. (2007)
Rheumatology 46, 776-782
   Abstract »    Full Text »    PDF »
The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.
B. D. Hondowicz, S. T. Alexander, W. J. Quinn III, A. J. Pagan, M. H. Metzgar, M. P. Cancro, and J. Erikson (2007)
Int. Immunol. 19, 465-475
   Abstract »    Full Text »    PDF »
TACI regulates IgA production by APRIL in collaboration with HSPG.
D. Sakurai, H. Hase, Y. Kanno, H. Kojima, K. Okumura, and T. Kobata (2007)
Blood 109, 2961-2967
   Abstract »    Full Text »    PDF »
The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells.
R. Nimmanapalli, M.-A. Lyu, M. Du, M. J. Keating, M. G. Rosenblum, and V. Gandhi (2007)
Blood 109, 2557-2564
   Abstract »    Full Text »    PDF »
Unique and conserved functions of B cell-activating factor of the TNF family (BAFF) in the chicken.
S. Kothlow, I. Morgenroth, Y. Graef, K. Schneider, I. Riehl, P. Staeheli, P. Schneider, and B. Kaspers (2007)
Int. Immunol. 19, 203-215
   Abstract »    Full Text »    PDF »
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
M.-A. Lyu, L. H. Cheung, W. N. Hittelman, J. W. Marks, R. C.T. Aguiar, and M. G. Rosenblum (2007)
Mol. Cancer Ther. 6, 460-470
   Abstract »    Full Text »    PDF »
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-{kappa}B pathway.
T. Endo, M. Nishio, T. Enzler, H. B. Cottam, T. Fukuda, D. F. James, M. Karin, and T. J. Kipps (2007)
Blood 109, 703-710
   Abstract »    Full Text »    PDF »
Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
D. Sene, N. Limal, P. Ghillani-Dalbin, D. Saadoun, J.-C. Piette, and P. Cacoub (2007)
Rheumatology 46, 65-69
   Abstract »    Full Text »    PDF »
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells.
C. V. Lee, S. G. Hymowitz, H. J. Wallweber, N. C. Gordon, K. L. Billeci, S.-P. Tsai, D. M. Compaan, J. Yin, Q. Gong, R. F. Kelley, et al. (2006)
Blood 108, 3103-3111
   Abstract »    Full Text »    PDF »
BAFF controls B cell metabolic fitness through a PKC{beta}- and Akt-dependent mechanism.
A. Patke, I. Mecklenbrauker, H. Erdjument-Bromage, P. Tempst, and A. Tarakhovsky (2006)
J. Exp. Med. 203, 2551-2562
   Abstract »    Full Text »    PDF »
A role for BLyS in the activation of innate immune cells.
S. K. Chang, B. K. Arendt, J. R. Darce, X. Wu, and D. F. Jelinek (2006)
Blood 108, 2687-2694
   Abstract »    Full Text »    PDF »
A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
N. D. Huntington, R. Tomioka, C. Clavarino, A. M. Chow, D. Linares, P. Mana, J. Rossjohn, T. G. Cachero, F. Qian, S. L. Kalled, et al. (2006)
Int. Immunol. 18, 1473-1485
   Abstract »    Full Text »    PDF »
Paucity of Clinical Disease despite Serological Autoimmunity and Kidney Pathology in Lupus-Prone New Zealand Mixed 2328 Mice Deficient in BAFF.
C. O. Jacob, L. Pricop, C. Putterman, M. N. Koss, Y. Liu, M. Kollaros, S. A. Bixler, C. M. Ambrose, M. L. Scott, and W. Stohl (2006)
J. Immunol. 177, 2671-2680
   Abstract »    Full Text »    PDF »
Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy.
K. Yoshimoto, Y. Takahashi, M. Ogasawara, Y. Setoyama, K. Suzuki, K. Tsuzaka, T. Abe, and T. Takeuchi (2006)
Int. Immunol. 18, 1189-1196
   Abstract »    Full Text »    PDF »
Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic Effects.
W. G. Halpern, P. Lappin, T. Zanardi, W. Cai, M. Corcoran, J. Zhong, and K. P. Baker (2006)
Toxicol. Sci. 91, 586-599
   Abstract »    Full Text »    PDF »
Space, Selection, and Surveillance: Setting Boundaries with BLyS..
J. P. Miller, J. E. Stadanlick, and M. P. Cancro (2006)
J. Immunol. 176, 6405-6410
   Abstract »    Full Text »    PDF »
APRIL and BAFF Promote Increased Viability of Replicating Human B2 Cells via Mechanism Involving Cyclooxygenase 2..
P. K. A. Mongini, J. K. Inman, H. Han, R. J. Fattah, S. B. Abramson, and M. Attur (2006)
J. Immunol. 176, 6736-6751
   Abstract »    Full Text »    PDF »
Constitutive NF-{kappa}B and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.
L. Fu, Y.-C. Lin-Lee, L. V. Pham, A. Tamayo, L. Yoshimura, and R. J. Ford (2006)
Blood 107, 4540-4548
   Abstract »    Full Text »    PDF »
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.
A. G. Brickner, A. M. Evans, J. K. Mito, S. M. Xuereb, X. Feng, T. Nishida, L. Fairfull, R. E. Ferrell, K. A. Foon, D. F. Hunt, et al. (2006)
Blood 107, 3779-3786
   Abstract »    Full Text »    PDF »
Phospholipase C{gamma}2 Dosage Is Critical for B Cell Development in the Absence of Adaptor Protein BLNK..
S. Xu, J. Huo, W.-K. Chew, M. Hikida, T. Kurosaki, and K.-P. Lam (2006)
J. Immunol. 176, 4690-4698
   Abstract »    Full Text »    PDF »
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.
S. F. Elsawa, A. J. Novak, D. M. Grote, S. C. Ziesmer, T. E. Witzig, R. A. Kyle, S. R. Dillon, B. Harder, J. A. Gross, and S. M. Ansell (2006)
Blood 107, 2882-2888
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882